Literature DB >> 16919177

Clinical management of paroxysmal nocturnal hemoglobinuria in pregnancy: a case report and updated review.

Stefania Fieni1, Laura Bonfanti, Dandolo Gramellini, Luigi Benassi, Roberto Delsignore.   

Abstract

UNLABELLED: Because women with paroxysmal nocturnal hemoglobinuria (PNH) are especially vulnerable to thromboembolic phenomena, pregnancy is a time of increased risk for both mother and fetus. However, pregnancies in affected women are rare; only case reports and small studies have been reported so far. We present the case of a 20-year-old woman with PNH who, while undergoing medical tests in preparation for a bone marrow transplant, was discovered to be pregnant. We also review the obstetric literature on pregnancy complicated by PNH, which indicates that both maternal and fetal mortality is exceptionally high (11.6% and 7.2%) with the major cause of maternal mortality being thromboembolism. Major maternal complications are more frequent postpartum (30.2%) than antepartum or intrapartum (16.3%). TARGET AUDIENCE: Obstetricians & Gynecologists, Family Physicians. LEARNING
OBJECTIVES: After completion of this article, the reader should be able to recall that paroxysmal nocturnal hemoglobinuria (PNH) during pregnancy increases adverse events for both the mother and the fetus, state that maternal and fetal mortality are both high, and explain that the major complications occur in the postpartum period.

Entities:  

Mesh:

Year:  2006        PMID: 16919177     DOI: 10.1097/01.ogx.0000234794.27485.59

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  16 in total

1.  Clinical management of paroxysmal nocturnal haemoglobinuria in pregnancy: three case reports.

Authors:  Anabela Melo; Rosário Gorgal-Carvalho; Joana Amaral; Maria Cristina Marques; Joaquim Andrade; João Tiago Guimarães; Mariana Guimarães
Journal:  Blood Transfus       Date:  2010-09-16       Impact factor: 3.443

Review 2.  Pesg PNH diagnosis, follow-up and treatment guidelines.

Authors:  Fahri Sahin; Olga Meltem Akay; Mesut Ayer; Mehmet Sinan Dal; Sehmus Ertop; Osman Ilhan; Volkan Karakus; Mehmet Ali Ozcan; Vildan Ozkocaman; Hayri Ozsan; Ozan Salim; Mahmut Tobu; Anil Tombak; Tulin Firatli Tuglular; Mehmet Yilmaz; Ali Unal; Mustafa Nuri Yenerel; Guray Saydam
Journal:  Am J Blood Res       Date:  2016-08-05

3.  Paroxysmal nocturnal hemoglobinuria and pregnancy before the eculizumab era: the French experience.

Authors:  Sophie de Guibert; Régis Peffault de Latour; Nathalie Varoqueaux; Hélène Labussière; Bernard Rio; Dominique Jaulmes; Jean-Richard Eveillard; Stéphanie Dulucq; Anne-Marie Stoppa; Didier Bouscary; François Girodon; Bernard Bonnotte; Djamila Laskri; Gérard Socié; Thierry Lamy
Journal:  Haematologica       Date:  2011-05-23       Impact factor: 9.941

Review 4.  Eculizumab in pregnancy: a narrative overview.

Authors:  Laura Sarno; Antonella Tufano; Giuseppe Maria Maruotti; Pasquale Martinelli; Mario M Balletta; Domenico Russo
Journal:  J Nephrol       Date:  2018-08-29       Impact factor: 3.902

Review 5.  Pregnancy outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: a Japanese experience and updated review.

Authors:  Naoyuki Miyasaka; Osamu Miura; Tatsuya Kawaguchi; Nobuyoshi Arima; Eriko Morishita; Kensuke Usuki; Yasuyoshi Morita; Kaichi Nishiwaki; Haruhiko Ninomiya; Akihiko Gotoh; Shinsaku Imashuku; Akio Urabe; Tsutomu Shichishima; Jun-Ichi Nishimura; Yuzuru Kanakura
Journal:  Int J Hematol       Date:  2016-02-08       Impact factor: 2.490

Review 6.  The complement system and adverse pregnancy outcomes.

Authors:  Jean F Regal; Jeffrey S Gilbert; Richard M Burwick
Journal:  Mol Immunol       Date:  2015-03-21       Impact factor: 4.407

Review 7.  Paroxysmal nocturnal haemoglobinuria.

Authors:  Anita Hill; Amy E DeZern; Taroh Kinoshita; Robert A Brodsky
Journal:  Nat Rev Dis Primers       Date:  2017-05-18       Impact factor: 52.329

Review 8.  Successful anticoagulant therapy for two pregnant PNH patients, and prospects for the eculizumab era.

Authors:  Yasuyoshi Morita; Jun-ichi Nishimura; Takahiro Shimada; Hirokazu Tanaka; Kentaro Serizawa; Yasuhiro Taniguchi; Mitsuhiro Tsuritani; Yuzuru Kanakura; Itaru Matsumura
Journal:  Int J Hematol       Date:  2013-03-02       Impact factor: 2.490

Review 9.  How I treat paroxysmal nocturnal hemoglobinuria.

Authors:  Robert A Brodsky
Journal:  Blood       Date:  2021-03-11       Impact factor: 25.476

10.  The pathophysiology of paroxysmal nocturnal hemoglobinuria and treatment with eculizumab.

Authors:  Richard Kelly; Stephen Richards; Peter Hillmen; Anita Hill
Journal:  Ther Clin Risk Manag       Date:  2009       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.